Annual report pursuant to Section 13 and 15(d)

Segments (Tables)

v2.4.0.8
Segments (Tables)
12 Months Ended
Dec. 31, 2013
Segment Reporting [Abstract]  
Information regarding our geographic activities
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 
For the years ended December 31,
(In thousands)
2013
 
2012
 
2011
Product revenues:
 
 
 
 
 
Pharmaceuticals
$
68,161

 
$
45,295

 
$
27,844

Diagnostics

 

 

Corporate

 

 

 
$
68,161

 
$
45,295

 
$
27,844

Revenue from services:
 
 
 
 
 
Pharmaceuticals
$

 
$

 
$

Diagnostics
10,833

 
395

 

Corporate
825

 
1,354

 
135

 
$
11,658

 
$
1,749

 
$
135

Revenue from transfer of intellectual property:
 
 
 
 
 
Pharmaceuticals
$
15,160

 
$

 
$

Diagnostics
1,551

 

 

Corporate

 

 

 
$
16,711

 
$

 
$

Operating loss from continuing operations:
 
 
 
 
 
Pharmaceuticals
$
(29,809
)
 
$
(6,797
)
 
$
(3,668
)
Diagnostics
(22,199
)
 
(14,259
)
 
(3,984
)
Corporate
(24,473
)
 
(15,628
)
 
(15,537
)
Less: Operating loss attributable to noncontrolling interests
(3,151
)
 
(585
)
 

 
$
(79,632
)
 
$
(37,269
)
 
$
(23,189
)
Depreciation and amortization:
 
 
 
 
 
Pharmaceuticals
$
8,234

 
$
6,367

 
$
2,804

Diagnostics
6,833

 
3,614

 
856

Corporate
149

 
179

 
170

 
$
15,216

 
$
10,160

 
$
3,830

Net loss from investment in investees:
 
 
 
 
 
Pharmaceuticals
(11,456
)
 
(2,062
)
 
(1,589
)
Diagnostics

 

 

Corporate

 

 

 
$
(11,456
)
 
$
(2,062
)
 
$
(1,589
)
Revenues:
 
 
 
 
 
U.S.
$
28,369

 
$
1,749

 
$
135

Chile
31,650

 
26,514

 
21,466

Spain
18,800

 
6,124

 

Israel
13,252

 
7,655

 

Mexico
4,459

 
5,002

 
6,378

 
$
96,530

 
$
47,044

 
$
27,979

(In thousands)
December 31,
2013
 
December 31,
2012
Assets:
 
 
 
Pharmaceuticals
$
1,065,033

 
$
142,299

Diagnostics
116,944

 
112,422

Corporate
209,539

 
35,109

 
$
1,391,516

 
$
289,830

Goodwill:
 
 
 
Pharmaceuticals
$
175,408

 
$
32,844

Diagnostics
50,965

 
47,606

Corporate

 

 
$
226,373

 
$
80,450